1. Introduction {#sec0005}
===============

The most commonly observed diastereoisomers derived from cholesterol are 7α-hydroxycholesterol and 7β-hydroxycholesterol (7α-HC and 7β-HC). These can be formed via free radical oxidation by initial abstraction of the C-7 hydrogen followed by reaction with oxygen to form a peroxyradical, hydrogen abstraction to form a peroxide and ultimately reduction to 7α- or 7β-HC ([@bib0085]) ([Fig. 1](#fig0005){ref-type="fig"}). These reactions may proceed in air during sample handling or in the biological systems, e.g. in the lysosomal storage disease Niemann Pick type C (NPC) ([@bib0010]). 7α-HC is also formed enzymatically from cholesterol by the enzyme cytochrome p450 7A1 (CYP7A1) in the first step of the neutral pathway of bile acid biosynthesis ([@bib0100]), while 7β-HC can be formed from 7-oxocholesterol (7-OC) in a reaction catalysed by hydroxysteroid dehydrogenase 11B1 (HSD11B1) ([@bib0055], [@bib0065], [@bib0080]). 7-OC can be formed from the cholesterol precursor 7-dehydrocholesterol (7-DHC) in a reaction also catalysed by CYP7A1 ([@bib0110]) and also by a free radical oxidation mechanism from cholesterol ([Fig. 1](#fig0005){ref-type="fig"}). Both 7-OC and 7β-HC are abundant in the disease Smith Lemli Opitz Syndrome (SLOS) where 7-DHC, the CYP7A1 substrate, is present at elevated concentrations ([@bib0050]). To understand the origin of 7α-HC and 7β-HC it is necessary to differentiate between them. While the epimers 7α-HC and 7β-HC can be resolved by gas chromatography (GC) ([@bib0030]) this is not always the case with liquid chromatography (LC) ([@bib0070]).Fig. 1Formation of 7-hydroxycholesterol (7-HC) and 7-oxocholesterol (7-OC) by radical initiated and enzymatic reactions. LOO^.^ corresponds to a lipid hydroperoxy radical and LOH to a hydroxy lipid. Enzyme catalysed reactions are shown in the blue boxes and radical initiated pathways in the red box. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)Fig. 1

Less commonly considered diastereoisomers are 24S- and 24R-hydroxycholesterols (24S-HC and 24R-HC). 24S-HC is formed from cholesterol by the enzyme CYP46A1, predominantly expressed in neurons in brain, however, the origin of 24R-HC is less well established ([@bib0100]). Most GC-mass spectrometry (MS) methods are not optimised to differentiate between these epimers and it is generally assumed that all 24-HC detected is the 24S-epimer. This may not necessarily be the case.

A further stereocentre of biological importance is at C-25. During bile acid biosynthesis side-chain shortening in the peroxisome the stereochemistry at C-25 of the C~27~ acid is changed from R to S by the enzyme alphamethylacyl-CoA racemase (AMACR). This is necessary for the next step in the pathway, catalysed by the peroxisomal enzyme acyl-coenzyme A oxidase 2 (ACOX2), which introduces a double bond between C-24 and C-25, to proceed and ultimately lead to a C~24~ acid ([@bib0100]). When found in plasma, cholestenoic acids are usually assumed to have R stereochemistry at C-25.

Here we describe how we have optimised the charge-tagging technique christened enzyme-assisted derivatisation for steroid analysis (EADSA) ([@bib0045]) to separate and identify oxysterol, cholestenoic and cholenoic acid diastereoisomers.

2. Materials and methods {#sec0010}
========================

2.1. Materials {#sec0015}
--------------

Human serum and plasma samples were from waste material from previous studies in Swansea ([@bib0005]) or supplied by the Reference Institute for Bioanalytics, Bonn, Germany as a reference material for interlaboratory comparison of oxysterol measurements ([@bib0060]). Written informed consent was obtained from all subjects in accordance with the Declaration of Helsinki. The study was conducted with institutional review board approval. The NIST standard reference material (SRM1950) was by prepared by NIST from plasma samples from 100 individuals between 40 and 50 years of age, whose ethnicity was representative of the US population and that included an equal number of men and women (Gaithersburg, MD) ([@bib0095]).

All reagents were from sources documented in ([@bib0015], [@bib0020]). Oxysterol, cholestenoic and cholenoic acid authentic standard were from Avanti Polar Lipids Inc (Alabaster, AL) or from kind donations by Professor Jan Sjövall, Karolinska Institute, Stockholm.

2.2. Methods {#sec0020}
------------

### 2.2.1. EADSA {#sec0025}

To enhance sensitivity, solubility in solvents used in reversed-phase chromatography and to enrich structure-informative fragmentation we employed EADSA. In brief, after separation of oxysterols and C~24~ and C~27~ acids from cholesterol and other hydrophobic sterols, an aliquot (A) of the oxysterol fraction containing the acids was oxidised with cholesterol oxidase from Streptomyces sp (Sigma-Aldrich, Dorset, UK) to convert 3β-hydroxy-5-ene structures to 3-oxo-4-enes. The oxo groups were then reacted with the Girard P reagent (GP) to generate GP-hydrazones which were separated from excess reagents on an OASIS HLB reversed phase solid phase extraction column (Waters, Elstree, UK). As some oxysterols naturally contain a 3-oxo-4-ene group e.g. 7α-hydroxycholest-4-en-3-one (7α-HCO), to avoid confusion with those oxidised by cholesterol oxidase to contain this function a separate aliquot of sample (B) was prepared in an identical fashion but in the absence of cholesterol oxidase. To allow the simultaneous analysis of aliquots (A) and (B), \[^2^H~5~\]GP was used to derivatise aliquots (A) and \[^2^H~0~\]GP to derivatise aliquots (B). The two aliquots were combined immediately before LC--MS analysis. Oxysterols derivatised with \[^2^H~5~\]GP will have a mass 5.0314 Da heavier than those derivatised with \[^2^H~0~\]GP. Note an alkaline hydrolysis step was not performed so free were oxysterols analysed not total oxysterols.

### 2.2.2. LC--MS^n^ {#sec0030}

Derivatised oxysterols and C~24~ and C~27~ acids were separated on a Hypersil Gold reversed phase column (Thermo-Fisher Scientific, Hemel Hempstead, UK) as described in ([@bib0020]) and analysed by electrospray ionisation (ESI) − MS and −MS with multistage fragmentation (MS^n^) on an Orbitrap Elite hydride linear ion trap (LIT) − Orbitrap mass spectrometer (Thermo-Fisher Scientific, Hemel Hempstead, UK). While the Orbitrap performed *m*/*z* scans at high resolution (120,000 full-width at half height definition) the LIT simultaneously performed MS^3^ scans on preselected precursor and product-ions.

3. Results {#sec0035}
==========

3.1. LC separation and MS^n^ fragmentation {#sec0040}
------------------------------------------

As discussed previously ([@bib0020]), GP-derivatised oxysterols fragment in the first MS/MS event (MS^2^) with the loss of the pyridine ring to give the \[M-Py\]^+^ fragment, \[M-84\]^+^ for \[^2^H~5~\]GP and \[M-79\]^+^ for \[^2^H~0~\]GP. \[M-Py\]^+^ ions then fragment in an MS^3^ (MS/MS/MS) event to give structurally informative fragment-ions showing cleavage in the ring-system, side-chain and with loss of H~2~O and CO and combinations thereof.

### 3.1.1. 7α-HC, 7β-HC and 7α-HCO {#sec0045}

7α-HC and 7β-HC are chromatographically resolved in our system ([Fig. 2](#fig0010){ref-type="fig"}A). The introduction of a polar hydroxyl group to the non-polar β-face of the sterol ring system reduces its hydrophobicity and retention on a C~18~ reversed-phase column. A reconstructed ion chromatogram (RIC, ± 5 ppm) from a typical serum sample is shown in [Fig. 2](#fig0010){ref-type="fig"}A. Both 7β-HC and 7α-HC give double peaks as a consequence of *syn* and *anti* conformers of the GP-derivative. The RIC in [Fig. 2](#fig0010){ref-type="fig"}A is for the aliquot treated with cholesterol oxidase and derivatised with \[^2^H~5~\]GP. [Fig. 2](#fig0010){ref-type="fig"}B shows the chromatogram generated from aliquot B in the absence of cholesterol oxidase and derivatised with \[^2^H~0~\]GP. This chromatogram reveals compounds with a *natural* oxo group, i.e. 7α-HCO and 7-OC. While 7α-HCO can be formed *in vivo* from 7α-HC by HSD3B7 ([Fig. 1](#fig0005){ref-type="fig"}), 7β-HCO is not formed from 7β-HC by this enzyme ([@bib0035]) and is thus absent. This, beside chromatographic resolution and differing MS^3^ spectra (see below), provides further evidence for the identity of the peaks assigned to the 7β-hydroxy epimer in chromatogram 2A. Absolute confirmation of identity was made by comparison with authentic standards. As peaks in aliquot (A) correspond to the sum of both 3β-hydroxy-5-ene and 3-oxo-4-ene compounds, while those in the (B) aliquot just to oxo compounds, quantification of 3β-hydroxy-5-ene compounds is easily performed by subtracting concentrations determined for a peak in (B) from those determined for the equivalent peak in (A). Concentration determined for peaks in (B) are those for the *natural* oxo compounds.Fig. 2Reconstructed-ion chromatograms (RICs) displaying how 7α-HC, 7β-HC, 7α-HCO and 7-OC vary in plasma in health and disease and according to sample storage. (A) RIC from NIST SRM1950 plasma treated with cholesterol oxidase and (B) in the absence of cholesterol oxidase. (C) RIC from a typical CTX plasma sample treated with cholesterol oxidase and (D) in the absence of cholesterol oxidase. (E) RIC from a typical SLOS plasma sample treated with cholesterol oxidase and (F) in the absence of cholesterol oxidase. (G) RIC from a dried plasma sample, transported to Swansea from Germany without precaution being taken against oxidation in air, treated with cholesterol oxidase and (H) in the absence of cholesterol oxidase. Aliquots of sample prepared in the presence of cholesterol oxidase were derivatised with \[^2^H~5~\]GP and those prepared in the absence of cholesterol oxidase with \[^2^H~0~\]GP. Analyte concentrations are given in supplementary Table S1 ([@bib0020], [@bib0050], [@bib0040], [@bib0115]).Fig. 2

The MS^3^ spectra of 7β-HC and 7α-HC/7α-HCO are similar but not identical ([Fig. 3](#fig0015){ref-type="fig"}). The 7α-hydroxy group is more labile with the result that the \[M-Py-18\]^+^ fragment-ion (*m*/*z* 437, [Fig. 4](#fig0020){ref-type="fig"}) dominates the MS^3^ spectrum and the \[M-Py-28-18-15\]^+^ (*m*/*z* 394) and \*c~2~ + 2-18 (*m*/*z* 231) fragment-ions are of greater relative abundant than in the MS^3^ spectrum of 7β-HC. On the other hand, the \[M-Py-28\]^+^ (*m*/*z* 427) and \*b~1~-12 (*m*/*z* 151) fragment-ions are of higher relative abundance in the spectrum of 7β-HC than 7α-HC (Figs. [3](#fig0015){ref-type="fig"}A and B & [4](#fig0020){ref-type="fig"}).Fig. 3MS^3^ (\[M^+^ → \[M-Py\]^+^ → ) spectra of (A) 7β-HC, (B) 7α-HC and (C) 7-OC. Aliquots of sample prepared in the presence of cholesterol oxidase were derivatised with \[^2^H~5~\]GP and those prepared in the absence of cholesterol oxidase with \[^2^H~0~\]GP.Fig. 3Fig. 4Fragmentation of 7-hydroxycholesterols. Ions of elevated relative abundance in the spectra of 7α- and 7β- epimers are indicated by arrows.Fig. 4

The abundance of 7α-HC and 7β-HC are of diagnostic value. One example is cerebrotendinous xanthomatosis (CTX) where the enzyme CYP27A1 is deficient resulting in reduced levels of its product (25R)26-hydroxycholesterol ((25R)26-HC) and greatly elevated levels of 7α-HC and 7α-HCO in plasma ([Fig. 2](#fig0010){ref-type="fig"}C and D) ([@bib0025]). In SLOS where both 7-DHC and 7-OC are elevated in plasma so is 7β-HC formed from 7-OC by HSD11B1 ([Fig. 2](#fig0010){ref-type="fig"}E and F). A complication when using 7-HC epimers or 7-OC in disease diagnosis is that each can be formed in air by reaction with oxygen ([Fig. 2](#fig0010){ref-type="fig"}G and H) ([@bib0105]).

### 3.1.2. 24S-HC and 24R-HC {#sec0050}

24S-HC elutes before 24R-HC ([Fig. 5](#fig0025){ref-type="fig"}A--D & E--G showing two different gradients). They give an essentially identical MS^3^ spectrum where the fragment ion '\*f at *m*/*z* 353 is prominent (Figs. [5](#fig0025){ref-type="fig"} H and I & [6](#fig0030){ref-type="fig"} ). This ion is very minor in closely eluting 25-hydroxycholesterol (25-HC) and (25R)26-HC (see Supplementary Fig. S1). By performing a RIC for *m*/*z* 353 in the MS^3^ chromatogram to give a multiple reaction monitoring (MRM) chromatogram for transitions \[M\]^+^ → \[M-Py\]^+^ → 353 the 24-HC epimers are highlighted. This is demonstrated for \[25,26,26,26,27,27,27-^2^H~7~\]24*S*-HC and \[25,26,26,26,27,27,27-^2^H~7~\]24*R*-HC authentic standards in [Fig. 5](#fig0025){ref-type="fig"}B (MS^3^ spectra shown in [Fig. 5](#fig0025){ref-type="fig"}H and I) and in a typical human serum sample in [Fig. 5](#fig0025){ref-type="fig"}D and in a CTX plasma sample in [Fig. 5](#fig0025){ref-type="fig"}F. The fragmentation pattern for the endogenous molecule is described by [Fig. 6](#fig0030){ref-type="fig"} and its MS^3^ spectrum shown in supplementary Fig. S1. Quantification can be performed using the MRM chromatograms for the authentic standard and endogenous molecules.Fig. 5Separation and fragmentation of 24S-HC and 24R-HC. (A) RIC for 24S-HC and 24R-HC using a 37 min gradient. Other peaks correspond to 22R-HC and 7α-HC. The hydroxycholesterols (HCs) are heavy isotope labelled with \[25,26,26,26,27,27,27-^2^H~7~\] and derivatised with \[^2^H~5~\]GP. (B) MRM chromatogram for the \[M\]^+^ → \[M-Py\]^+^ → 353.3 ± 0.3 transition. 22R-HC also shows a fragment ion at *m*/*z* 353.3 (see Supplementary Fig. S1A). (C) RIC for monohydroxycholesterols in a typical human serum sample and (D) MRM chromatogram for the \[M\]^+^ → \[M-Py\]^+^ → 353.3 ± 0.3 transition, highlighting 24-HC, in the same sample. (E) RIC for HCs in a CTX plasma sample using a 17 min gradient. (F) MRM chromatogram for the \[M\]^+^ → \[M-Py\]^+^ → 353.3 ± 0.3 transition from the CTX patient using the 17 min gradient ([@bib0020]). (G) RIC for \[^2^H~7~\]24S-HC and \[^2^H~7~\]24R-HC using the 17 min gradient. (H) MS^3^ (\[M^+^ → \[M-Py\]^+^→) spectra of \[^2^H~7~\]24S-HC and (I) \[^2^H~7~\]24R-HC. Note in the spectra of the \[^2^H~7~\]24-HC molecules fragment ions are observed at *m*/*z* 444, 434, 416 and 401 which are 7 Da heavier than equivalent fragment ions in the \[^2^H~0~\]24-HC native molecules (see Supplementary Fig. S1C & S1F and [Fig. 6](#fig0030){ref-type="fig"}). Analyte concentrations are given in supplementary Table S1.Fig. 5Fig. 6Fragmentation of 24-hydroxycholesterols.Fig. 6

### 3.1.3. 3,7-Dihydroxycholest-5-en-26-oic and 7-Hydroxy-3-oxocholest-4-en-26-oic acids {#sec0055}

Both 3β,7α-dihydroxycholest-5-en-(25*R*)26-oic (3β,7α-diHCA(25R)) and 7α-hydroxy-3-oxocholest-4-en-(25*R*)-26-oic (7αH,3O-CA(25R)) acids are found in plasma ([Fig. 7](#fig0035){ref-type="fig"}A and B). They can be formed via both the neutral and acidic pathways of bile acid biosynthesis ([@bib0100]). Once a 7α-hydroxy group is present on the B-ring, the sterol becomes a substrate for HSD3B7 and the 3β-hydroxy-5-ene is converted to a 3-oxo-4-ene. Both acids when derivatised give double peaks corresponding to *syn* and *anti* confirmers of the GP-hydrazone. Surprisingly, in plasma a quartet rather than a doublet of peaks is observed in the appropriate RIC, each giving an identical MS^3^ spectrum ([Fig. 7](#fig0035){ref-type="fig"}D and E). Custom synthesis of \[^2^H~2~\]-labelled 25R and 25S epimers (supplementary Fig. S2) showed that the smaller peaks of the quartet correspond to the 25S epimers, 3β,7α-diHCA(25S) and 7αH,3O-CA(25S), while the larger peaks correspond to the 25R epimers.Fig. 7Separation and fragmentation of diastereoisomers of 3,7-dihydroxycholest-5-en-26-oic and 7-hydroxy-3-oxocholest-4-en-26-oic acids. (A) RIC from NIST SRM1950 plasma showing the separation of 3β,7β-diHCA(25S), 3β,7β-diHCA(25R), 3β,7α-diHCA(25S) and 3β,7α-diHCA(25R). Peak intensities in the time window 3--5 min have been multiplied by 2. (B) The 3β,7β-diHCA epimers are not substrates for HSD3B7 so do not give 7βH,3O-CA compounds, while 3β,7α-diHCA are and give 7αH,3O-CA epimers. (C) MS^3^ (\[M\]^+^ → \[M-Py\]^+^ → ) spectra of 3β,7β-diHCA(25R), (D) 3β,7α-diHCA(25S) and (E) 3β,7α-diHCA(25R). Aliquots of sample prepared in the presence of cholesterol oxidase were derivatised with \[^2^H~5~\]GP and those prepared in the absence of cholesterol oxidase with \[^2^H~0~\]GP. Analyte concentrations are given in supplementary Table S1.Fig. 7

Further possible diastereomers are 3β,7β-dihydroxycholest-5-en-(25*R*)26-oic (3β,7β-diHCA(25R)) and 3β,7β-dihydroxycholest-5-en-(25*S*)26-oic (3β,7β-diHCA(25S)). As HSD3B7 is not active on sterols with a 7β-hydroxy group the 7β-hydroxy-3-oxo-4-ene acids are not expected to present endogenously ([@bib0035]). Close scrutiny of the RIC shown in [Fig. 7](#fig0035){ref-type="fig"}A reveals a peak with retention time and giving an MS^3^ spectrum ([Fig. 7](#fig0035){ref-type="fig"}C) identical to the 3β,7β-diHCA(25R) authentic standard. This peak is absent in [Fig. 7](#fig0035){ref-type="fig"}B where the sample was prepared in the absence of cholesterol oxidase. In keeping with the MS^3^ spectra of 7α-HC and 7-βHC, the \[M-Py-18\]^+^ ion at *m*/*z* 467 dominates the spectrum of the 7α-epimers, with the \[M-Py-28-18-15\]^+^ (*m*/*z* 424) and \*c~2~ + 2-18 (*m*/*z* 231) being of greater relative abundance than in the spectrum of the 7β-epimer ([Fig. 8](#fig0040){ref-type="fig"}). On the other hand the fragment ions \[M-Py-28\]^+^ (*m*/*z* 457) and \*b~1~-12 (*m*/*z* 151) are of greater relative abundance in the spectrum of the 7β-epimer. An early eluting shoulder can be observed on the chromatographic peak assigned to the 3β,7β-diHCA(25R) diastereomer. This shoulder is absent in a chromatogram of the authentic 3β,7β-diHCA(25R) standard, but gives an identical MS^3^ spectrum. It is thus assigned to 3β,7β-diHCA(25S).Fig. 8Fragmentation of 3β,7α-diHCA and 3β,7β-diHCA. Ions of elevated relative abundance in the spectra of 7α- and 7β- epimers are indicated by arrows.Fig. 8

### 3.1.4. 3,7-Dihydroxychol-5-en-24-oic and 7-Hydroxy-3-oxochol-4-en-24-oic acids {#sec0060}

After side-chain shortening in the peroxisome C~27~ 7-hydroxy acids will be converted to their C~24~ equivalents, we thus screened for the presence of 3β,7α-dihydroxychol-5-en-24-oic (3β,7α-diH-Δ^5^-BA), 7α-hydroxy-3-oxochol-4-en-24-oic (7αH,3O-Δ^4^-BA) and 3β,7β-dihydroxychol-5-en-24-oic (3β,7β-Δ^5^-BA) acids in plasma. 7β-Hydroxy-3-oxochol-4-en-24-oic acid should not be formed via HSD3B7 oxidation due to the presence of a 7β- rather than a 7α-hydroxy group ([@bib0035]). Shown in [Fig. 9](#fig0045){ref-type="fig"}A and B is the appropriate RIC for 3β,7-diH-Δ^5^-BA and 7αH,3O-Δ^4^-BA. Comparison with authentic standards reveals that the first pair of peaks in [Fig. 9](#fig0045){ref-type="fig"}A correspond to 3β,7β-diH-Δ^5^-BA (*syn* and *anti* GP conformers) while the latter correspond to 3β,7α-diH-Δ^5^-BA. As expected only the latter pair of peaks corresponding to 7αH,3O-Δ^4^-BA are observed in [Fig. 9](#fig0045){ref-type="fig"}B recorded on the sample prepared in the absence of cholesterol oxidase. MS^3^ spectra of the 3β,7β-diH-Δ^5^-BA and 3β,7α-diH-Δ^5^-BA epimers are shown in [Fig. 9](#fig0045){ref-type="fig"}C and D and as illustrated in [Fig. 10](#fig0050){ref-type="fig"} show distinctive features of the respective 7β- and 7α-epimers.Fig. 9Separation and fragmentation of diastereoisomers of 3,7-dihydroxychol-5-en-24-oic and 7-hydroxy-3-oxochol-4-en-24-oic acids. (A) RIC from NIST SRM1950 plasma showing the separation of 3β,7β-diH-Δ^5^-BA and 3β,7α-diH-Δ^5^-BA. (B) The 3β,7β-diH-Δ^5^-BA is not a substrate for HSD3B7 so does not give 7βH,3O-Δ^4^-BA, while 3β,7α-diH-Δ^5^-BA is and gives 7αH,3O-Δ^4^-BA. MS^3^ (\[M\]^+^ → \[M-Py\]^+^ → ) spectra of (C) 3β,7β-diH-Δ^5^-BA and (D) 3β,7α-diH-Δ^5^-BA. Aliquots of sample prepared in the presence of cholesterol oxidase were derivatised with \[^2^H~5~\]GP and those prepared in the absence of cholesterol oxidase with \[^2^H~0~\]GP. Analyte concentrations are given in supplementary Table S1.Fig. 9Fig. 10Fragmentation of 3β,7α-diH-Δ^5^-BA and 3β,7β-diH-Δ^5^-BA. Ions of elevated relative abundance in the spectra of 7α- and 7β- epimers are indicated by arrows.Fig. 10

4. Discussion {#sec0065}
=============

It has previously been shown that 7β-HC can be formed not only ex *vivo* through autoxidation during sample handling ([@bib0105]), but also in *vivo* enzymatically from 7-OC by HSD11B1 ([@bib0055], [@bib0065], [@bib0080]) and perhaps also by free radical reactions from cholesterol ([@bib0085]) ([Fig. 1](#fig0005){ref-type="fig"}). In fact, 7β-HC is elevated in plasma from people with SLOS who also show elevated 7-OC ([@bib0050]) and also in patients suffering from NPC disease who similarly show elevated 7-OC in plasma (data not shown). Interestingly, Alvelius et al. showed that bile acids with a 3β,7β-diH-Δ^5^-BA core structure were formed by a patient with NPC disease ([@bib0010]), while Evans and Natowicz also found bile acids probably with the same structure formed by a patient with SLOS ([@bib0090]). 7β-HC may represent an early metabolite in the biosynthesis of these acids. Using our optimised EADSA approach we also find comparatively (to the 7α-epimers) low levels of 7β-HC, 3β,7β-diHCA and 3β,7β-diH-Δ^5^-BA in plasma from healthy individuals, see Supplementary Table S1 ([@bib0005]).

In healthy individuals, we identify four diastereoisomers for 3β,7-diHCA. Besides the 25R epimers of 3β,7α-diHCA and 3β,7β-diHCA we also identify the corresponding 25S epimers. The interconversion of 25R and 25S epimers as CoA thioesters is catalysed by AMACR, the next enzyme in the bile acid biosynthesis pathway ACOX2 requiring 25S stereochemistry of the substrate ([@bib0100]). It has recently been reported that a defect in ACOX2 leads to liver fibrosis, mild ataxia, and cognitive impairment ([@bib0120]). A blockage in the bile acid biosynthesis pathway at this point would be expected to lead to elevated levels of both epimers of 3β,7α-diHCA and 3β,7β-diHCA in plasma which could easily be determined by the EADSA method.

24S-HC is the dominant oxysterol in brain. It is formed by CYP46A1 mediated oxidation of cholesterol ([@bib0100]). The origin of the 24R-epimer is less clear. Interestingly, 24R-HC is present in brain of the CYP46A1 knockout mouse indicating a source other than a reaction catalysed by CYP46A1 ([@bib0075]).

5. Conclusions {#sec0070}
==============

We describe here how the EADSA method has been optimised to reveal diastereoisomers of oxysterols, cholestenoic and cholenoic acids. Our observations highlight the extreme complexity of the plasma sterolome.

Appendix A. Supplementary data {#sec0080}
==============================

The following are Supplementary data to this article:
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